Urinary tract infections and reduced risk of bladder cancer in Los Angeles

British Journal of Cancer

Volumn 100, Issue 5, 2009, Pages 834-839

  Jiang, X ^a,c   Castelao, J E ^a   Groshen, S ^a   Cortessis, V K ^a   Shibata, D ^a   Conti, D V ^a   Yuan, J M ^b   Pike, M C ^a   Gago Dominguez, M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antibiotics; Bladder cancer; Bladder infection; Los Angeles; Urinary tract infection

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BLADDER CANCER; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HUMAN; KIDNEY INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; TRANSITIONAL CELL CARCINOMA; UNITED STATES; URINARY TRACT INFECTION;

ADULT; CARCINOMA, TRANSITIONAL CELL; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; LOS ANGELES; MALE; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS; SMOKING; URINARY BLADDER NEOPLASMS; URINARY TRACT INFECTIONS;

EID: 61749086577     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604889     Document Type: Article

References (40)

1. Alexandroff AB, Jackson AM, O'Donnell MA, James K (1999) BCG immunotherapy of bladder cancer: 20 years on. Lancet 353: 1689-1694
2. Aranha O, Wood Jr DP, Sarkar FH (2000) Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res 6: 891-900
3. Aranha O, Zhu L, Alhasan S, Wood Jr DP, Kuo TH, Sarkar FH (2002) Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells. J Urol 167: 1288-1294
4. Bernstein L, Ross RK (1991) Cancer in Los Angeles County. University of Southern California: Los Angeles, CA
5. Burin GJ, Gibb HJ, Hill RN (1995) Human bladder cancer: evidence for a potential irritation-induced mechanism. Food Chem Toxicol 33: 785-795
6. Castelao JE, Yuan JM, Gago-Dominguez M, Skipper PL, Tannenbaum SR, Chan KK, Watson MA, Bell DA, Coetzee GA, Ross RK, Yu MC (2004) Carotenoids/vitamin C and smoking-related bladder cancer. Int J Cancer 110: 417-423
7. Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK (2000) Nonsteroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 82: 1364-1369
8. Castelao JE, Yuan JM, Skipper PL, Tannenbaum SR, Gago-Dominguez M, Crowder JS, Ross RK, Yu MC (2001) Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst 93: 538-545
9. Claude J, Kunze E, Frentzel-Beyme R, Paczkowski K, Schneider J, Schubert H (1986) Life-style and occupational risk factors in cancer of the lower urinary tract. Am J Epidemiol 124: 578-589
10. Davis CP, Cohen MS, Hackett RL, Anderson MD, Warren MM (1991) Urothelial hyperplasia and neoplasia. III. Detection of nitrosamine production with different bacterial genera in chronic urinary tract infections of rats. J Urol 145: 875-880
11. Ebisuno S, Inagaki T, Kohjimoto Y, Ohkawa T (1997) The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro. Cancer 80: 2263-2267
12. Fihn SD (2003) Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 349: 259-266
13. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, Marsh JV, Spear S, Sobel JD, Marty MJ, Marrs CF (2000) Risk factors for second urinary tract infection among college women. Am J Epidemiol 151: 1194-1205
14. Gago-Dominguez M, Bell DA, Watson MA, Yuan JM, Castelao JE, Hein DW, Chan KK, Coetzee GA, Ross RK, Yu MC (2003) Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 24: 483-489
15. Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK (2001) Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 91: 575-579
16. Gonzalez CA, Errezola M, Izarzugaza I, Lopez-Abente G, Escolar A, Nebot M, Riboli E (1991) Urinary infection, renal lithiasis and bladder cancer in Spain. Eur J Cancer 27: 498-500
17. Howe GR, Burch JD, Miller AB, Cook GM, Esteve J, Morrison B, Gordon P, Chambers LW, Fodor G, Winsor GM (1980) Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst 64: 701-713
18. IARC (1994) Infection with schistosomes (Schistosoma haematobium, Schistosoma mansoni and Schistosoma japonicum). IARC Monogr Eval Carcinog Risks Hum 61: 45-119
19. Jhamb M, Lin J, Ballow R, Kamat AM, Grossman HB, Wu X (2007) Urinary tract diseases and bladder cancer risk: a case-control study. Cancer Causes Control 18: 839-845
20. Jiang X, Castelao JE, Groshen S, Cortessis VK, Ross RK, Conti DV, Gago-Dominguez M (2007) Alcohol consumption and risk of bladder cancer in Los Angeles County. Int J Cancer 121: 839-845
21. Jiang X, Castelao JE, Groshen S, Cortessis VK, Shibata DK, Conti DV, Gago-Dominguez M (2008) Water intake and bladder cancer risk in Los Angeles County. Int J Cancer 123: 1649-1656
22. Kamat AM, Lamm DL (2004) Antitumor activity of common antibiotics against superficial bladder cancer. Urology 63: 457-460
23. Kantor AF, Hartge P, Hoover RN, Fraumeni Jr JF (1988) Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res 48: 3853-3855
24. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni Jr JF (1984) Urinary tract infection and risk of bladder cancer. Am J Epidemiol 119: 510-515
25. Kjaer SK, Knudsen JB, Sorensen BL, Moller Jensen O (1989) The Copenhagen case-control study of bladder cancer. V. Review of the role of urinary-tract infection. Acta Oncol 28: 631-636
26. La Vecchia C, Negri E, D'Avanzo B, Savoldelli R, Franceschi S (1991) Genital and urinary tract diseases and bladder cancer. Cancer Res 51: 629-631
27. Masters PA, O'Bryan TA, Zurlo J, Miller DQ, Joshi N (2003) Trimethoprimsulfamethoxazole revisited. Arch Intern Med 163: 402-410
28. Michaud DS (2007) Chronic inflammation and bladder cancer. Urol Oncol 25: 260-268
29. Michaud DS, Platz EA, Giovannucci E (2007) Gonorrhoea and male bladder cancer in a prospective study. Br J Cancer 96: 169- 171
30. Mommsen S, Sell A (1983) Prostatic hypertrophy and venereal disease as possible risk factors in the development of bladder cancer. Urol Res 11: 49-52
31. Piper JM, Matanoski GM, Tonascia J (1986) Bladder cancer in young women. Am J Epidemiol 123: 1033-1042
32. Seay TM, Peretsman SJ, Dixon PS (1996) Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. J Urol 155: 757-762
33. Sheffield JS, Cunningham FG (2005) Urinary tract infection in women. Obstet Gynecol 106: 1085-1092
34. Stamm WE (2002) Scientific and clinical challenges in the management of urinary tract infections. Am J Med 113(Suppl 1A): 1S-4S
35. Stamm WE, Hooton TM (1993) Management of urinary tract infections in adults. N Engl J Med 329: 1328-1334
36. Sturgeon SR, Hartge P, Silverman DT, Kantor AF, Linehan WM, Lynch C, Hoover RN (1994) Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 5: 218-225
37. Wong ES, Stamm WE (1983) Urethral infections in men and women. Annu Rev Med 34: 337-358
38. Yu MC, Ross RK (2002) Bladder cancer: epidemiology. In Encyclopedia of Cancer, Bertino JR (ed) 2nd edn, Vol. 1, pp 215-221. Academic Press: San Diego
39. Zasloff M (2007) Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol 18: 2810-2816
40. Zehavi-Willner T, Shalit I (1992) The inhibitory effect of ciprofloxacin on proliferation of a murine bladder carcinoma cell line. J Antimicrob Chemother 29: 323-328